http://www.100md.com 毛新，王 平，陈新隆，李洪荣

胸腺瘤外科学；预后,,胸腺瘤外科学；预后,1资料与方法,2结果,3讨论,【参考文献】

     【摘要】 目的 对128例胸腺瘤进行临床分析，了解胸腺瘤手术与分期、预后的关系。方法 总结128例胸腺瘤患者，按Masaoka分期法进行分期。分析不同分期胸腺瘤与生存率之间的关系。结果 完整手术切除109例(85.1%)，姑息性切除14例(10.9%)，探查活检5例(3.8%)，其中有1例死亡(0.8%)。5年、10年生存率Ⅰ期为91.4%、84.5%，Ⅱ期为70.6%、52.9%，Ⅲ期为50.0%、28.6%，Ⅳa期为14.3%、0。结论 胸腺瘤治疗应尽可能完整地切除肿瘤及部分周围组织，以达到手术彻底切除。Masaoka分期是主要预后因素。

    【关键词】 胸腺瘤外科学；预后

    Report on surgical treatment of thymoma in 128 patients

    MAO Xin,WANG Ping,CHEN Xin-long,et al.Department of Thoracic Surgery,Yunnan Provincial First People’s Hospital,Kunming 650032,China

    【Abstract】 Objective To analyze the characteristics of operation and the prognosis in 128 patients with thymoma.Methods Data of 128 patients operated for thymoma were collected.The distribution according to Masaoka staging showed stage Ⅰ in 77 patients,stage Ⅱ in 23 cases,stage Ⅲ in 19 cases,stage Ⅳa in 9 cases.The relation between stage and survial rate was analyzed.Results Of the 128 patients,109 underwent complete resection,14 underwent palliative operation,and 5 were biopsied only.One patient died of operation.The 5- and 10- year survial rates were 91.4%,84.5% for stage Ⅰ,70.6%,52.9% for stage Ⅱ,50.0%,28.6% for stage Ⅲ,14.3%,0 for stage Ⅳa,respectively.Conclusion The best treatment for thymoma is to resect it as completely as possible.Masaoka’s clinical staging is an important prognostic factor. ......